Subcutaneous Self Injection Markets, 2024 - Why it's Growing

News provided by

Research and Markets

29 Jan, 2018, 12:30 GMT

DUBLIN, Jan. 29, 2018 /PRNewswire/ --

The "Subcutaneous Self Injection Markets to 2024" report has been added to ResearchAndMarkets.com's offering.

Because of the ongoing need for repeat dosing posed by chronic diseases, these indications represent significant drug volume and revenue opportunities, while simultaneously challenging the industry to develop products that meet the unique needs of the non-professional caregiver.

For drugs designed to be administered by the patient, therapy-specific packaging is improving adherence and treatment outcomes. In the area of delivery, reusable injection devices designed to accept prefilled syringes or drug cartridges are improving ease-of-use and increasing the alternative device share of the growing self-injection market.

Subcutaneous Self Injection Markets - What You Will Learn

  • Provides detailed analysis of self-administered subcutaneous drug products, drug delivery and device strategies, and product development factors
  • Assesses key markets, market dynamics and market demographics
  • Analyzes therapeutic demand drivers and evaluates SC drug products in nine key therapeutic segments
  • Provides market data and forecasts to 2024
  • Profiles market sector participants, their product development activities, business strategies, and corporate alliances and affiliations
  • Assesses the importance of alliances and partnerships on self-administered subcutaneous drug product commercialization
  • Evaluates the impact of economic, technology, and regulatory factors.

Report Value Chain - Who Should Read the Report

Development

  • Drug Developers
  • Device Suppliers
  • CMOs
  • Components/APIs
  • Testing/Validation
  • Clinical Trial Mgmt

Industry

  • Pharma Managers
  • Biotech Managers
  • Drug Marketers
  • Industry Strategists
  • Financial Analysts
  • Management Consultants

Market

  • Clinical Managers
  • Drug Distributors
  • Pharma Regulators
  • FDA Consultants
  • Managed Care Managers

Key Topics Covered:

1. Executive Summary

2. The Market Opportunity

3. Subcutaneous Self-Administration - Why it's Growing

  • The Evolving Drug Pipeline
  • Device and Packaging Technology Advances
  • Shifting Patient Demographics
  • Healthcare Economics
  • Demand Drivers
  • Innovation in Prefilled Device Designs
  • Therapeutic Targets and Treatment
  • Competitive Landscape
  • Risk Factors

4. Subcutaneous Delivery Device Design Factors

  • Ergonomics and Ease of Use
  • Safety Features
  • Needle Insertion Depth
  • Dose Inspection/Injection Confirmation
  • Lyophilized Drugs/Reconstitution
  • High Viscosity Drugs
  • High Volume Drugs

5. Subcutaneously Delivered Drugs - Delivery Device Strategies

6. Handheld Devices

  • Autoinjectors
  • Pen Injectors
  • Prefilled Syringes
  • Other Handheld Devices
  • Wearable Devices
  • Patch Pumps
  • Large Volume Wearable Devices

7. Subcutaneous Self-Administration

  • Therapeutic Sector Product Analysis & Forecasts
  • Anticoagulants
  • Antivirals
  • Autoimmune Diseases
  • Diabetes
  • Hematopoietics
  • Hormone Replacement
  • Neurology
  • Osteoporosis
  • Reproductive Health

8. Market Factors

  • Regulatory Issues
  • DTC Marketing
  • Patient Education

9. Market Sector Participant Profiles

For more information about this report visit https://www.researchandmarkets.com/research/mj5fvp/subcutaneous_self?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com